Form4insider filings, from the source

SEC Form 4 · accession 0001193125-26-281119

Dyne Therapeutics, Inc. · DYN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Dirk Kersten
Director
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001818794

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4Jun 22, 2026S190,676$20.5703D3,921,542ISee footnote
Common StockF5,F3,F4Jun 23, 2026S71,629$21.0357D3,849,913ISee footnote
Common StockF6,F3,F4Jun 23, 2026S1,657$21.4742D3,848,256ISee footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses